HHS must improve both how it measures and plans to increase the use of EHRs in post-acute care settings, according to a GAO report.
What you don't measure, you can't improve. But if you measure everything, you are at risk of sending false signals about what's important and what's not.
The hearing, titled “The Affordable Care Act on Shaky Ground: Outlook and Oversight,” is being held jointly by the House Energy and Commerce subcommittees on health and oversight and investigations.
The report was requested by two Republicans in Congress who have suggested per-capita caps in Medicaid as part of a plan for replacing the Affordable Care Act.
No one has articulated a strategy for removing the estimated 350,000 mentally ill people incarcerated in the nation's jails and prisons. And no one is talking about how to fund a sharp increase in the number of long-term psychiatric beds in hospitals and other institutions. They clearly are needed.
A new federal rule will encourage states to ramp up auditing of Medicaid managed-care insurers, many of which keep their medical spending hidden from public view.
Georgia Gov. Nathan Deal has signed legislation that allows the state to provide funds to centers that offer medical and other services to pregnant women while discouraging them from getting abortions.
Federal investigators found significant cybersecurity weaknesses in the health insurance websites of California, Kentucky and Vermont that could enable hackers to get their hands on sensitive personal information about hundreds of thousands of people. And some of those flaws have yet to be fixed.
The CMS needs to do a better job overseeing the 12 state-administered demonstration programs intended to improve care of people who are eligible for both Medicare and Medicaid, according to the U.S. Government Accountability Office.
The Medicare Payment Advisory Commission has backed a proposal to reduce Part B drug payment rates for hospitals participating in the 340B Drug Pricing Program, though members had signaled they would oppose it.
The Food and Drug Administration is speeding up its review of new drugs, yet often fails to keep track of safety issues with those medicines once they reach patients, according to government investigators.
Prescribing a climate remedy: Healthcare leaders aim to affect international climate change negotiations
For an industry that loves to promote the “triple aim” buzz phrase, the U.S. healthcare system often leaves out one important element.